Daily non-political popular news in brief.

Outcomes for patients with hepatitis B who need liver transplants

Survival rates are similar among patients with hepatitis B who are listed for liver transplantation, whether or not they have hepatocellular carcinoma (HCC), according to a new study in the March 2007 issue of Liver Transplantation. An accompanying editorial suggests that these results affirm the current policy on the allocation of donor livers.

Read more »

Keywords: outcomes, patients, hepatitis, liver, transplants, outcome, patient, hepatiti, transplant

« Previous | Next »

Similar news on "Outcomes for patients with hepatitis B who need liver transplants":

1. Research shows cord blood comparable to matched bone marrow
   06-07-2007 · EurekAlert!
   University of Minnesota researchers report that umbilical cord blood transplants may offer blood cancer patients better outcomes than bone marrow transplants, according to an analysis of outcome data performed at the Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee.
   Similar news · Read more »
   
2. Predicting outcomes before and after liver transplants
   08-02-2007 · EurekAlert!
   Two studies examine whether sodium levels can be used to predict mortality while waiting for and following transplant
   Similar news · Read more »
   
3. Mayo Clinic Proceedings contributors discuss impact of donor organ allocation system
   02-06-2008 · EurekAlert!
   Liver transplant is a life saving treatment option for people with end-stage liver disease. Unfortunately, the need for donor livers far exceeds the supply. Each year only about one-third of people who need a donor liver will receive one, and some patients die while waiting. In the February issue of Mayo Clinic Proceedings, physicians explore how the current system for allocating donor organs in the United States affects outcomes for patients with end-stage liver disease.
   Similar news · Read more »
   
4. Steroid-free medication lowers rejection rate for kidney transplants
   12-13-2006 · EurekAlert!
   Kidney transplant recipients are typically required to take daily steroids as part of their anti-rejection medications. However, long-term steroid use has significant side effects. A new study in Clinical Transplantation explored a combination of steroid-free medications that resulted in excellent patient outcomes and a very low rejection rate.
   Similar news · Read more »
   
5. 24-week course of interferon-alpha therapy prolongs survival in patients hepatitis C virus
   11-02-2007 · EurekAlert!
   A group at Hiroshima University Hospital performed a matched historical controlled study on whether a 24-week course of interferon-alpha therapy, after curative treatment for primary hepatocellular carcinoma associated with hepatitis C virus, could influence tumor recurrence, patient survival, and liver function. Patients with sustained virological responses had reduced recurrence, prolonged survival and a preserved liver function. The group also determined that viral eradication was the most important factor in such patients.
   Similar news · Read more »
   
6. JCI table of contents: Aug. 23, 2007
   08-23-2007 · EurekAlert!
   This release contains summaries, links to PDFs and contact information for the following newsworthy papers to be published online, Aug. 23, 2007, in the JCI, including: New weapon to fight leukemia; Inhaling helps heal liver transplant recipients; Being fat needn't be all bad news; DNA provides clues to outcome in patients with liver cancer; Risk factor for heart disease: Just say NO; Building muscle requires Foxo1; and others.
   Similar news · Read more »
   
7. Liver cancer patients with high serum levels of hepatitis B virus face poorer outcomes
   06-01-2007 · EurekAlert!
   Researchers report their findings from the first-ever study examining the prognostic value of serum HBV DNA levels for patients with liver cancer undergoing chemotherapy.
   Similar news · Read more »
   
8. 'Mini transplant' patients' outcomes similar using related and unrelated donor cells
   12-03-2007 · EurekAlert!
   People who undergo nonmyeloablative stem-cell transplants, or 'mini transplants,' for leukemia, lymphoma and other blood cancers have comparable outcomes regardless of whether they receive tissue-matched stem cells from a related or unrelated donor, according to new findings by researchers at Fred Hutchinson Cancer Research Center.
   Similar news · Read more »
   
9. Risk factors for diabetes following liver transplant
   01-04-2007 · EurekAlert!
   A new study on risk factors of new-onset diabetes mellitus (NODM) following liver transplant found that a history of obesity, impaired fasting glucose and hepatitis C infection (HCV) paired with the use of a particular immunosuppressant are associated with an increased risk of NODM. Since all of these factors can be detected prior to undergoing a transplant, treatment should be tailored to the patient's risk.
   Similar news · Read more »
   
10. HCV patients survival after liver transplantation is not improving
    05-02-2007 · EurekAlert!
    For liver transplant recipients without hepatitis C, survival has improved over time. However, for recipients with HCV, survival has not improved.
    Similar news · Read more »